Medicare Part D plan designs hold steady in initial wake of Inflation Reduction Act implementation, researchers find

A recent study led by health services policy and management assistant professor David Anderson examined changes in Medicare Part D plans (both Medicare Advantage plans with drug coverage and stand-alone prescription drug plans) to assess how insurers may have changed various aspects of the plans in response to the 2022 Inflation Reduction Act. Published in Health Affairs, the researchers' findings showed that insurers reacted primarily by lowering premiums and increasing deductibles.

Read it at Medical Xpress ↗

← Front page